SARS-CoV-2

You have access
REPLY TO LETTER TO THE EDITOR: POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19
NagaVaraKishore Pillarsetty, Lukas Carter, Jason S. Lewis and Thomas Reiner

Journal of Nuclear Medicine April 23, 2021, jnumed.121.261950; DOI: https://doi.org/10.2967/jnumed.121.261950
Open Access
Cyclic gallium-68 labeled peptides for specific detection of human angiotensin-converting enzyme 2
Matthew Parker, Joseph Blecha, Oren Rosenberg, Michael Ohliger, Robert R Flavell and David M Wilson

Journal of Nuclear Medicine February 26, 2021, jnumed.120.261768; DOI: https://doi.org/10.2967/jnumed.120.261768
Open Access
α_vβ₆-Targeted Molecular PET/CT Imaging of the Lungs After SARS-CoV-2 Infection
Cameron C. Foster, Ryan A. Davis, Sven H. Hausner and Julie L. Sutcliffe

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1717-1719; DOI: https://doi.org/10.2967/jnumed.120.255364
Open Access
Oncology-Inspired Treatment Options for COVID-19
Nagavarakishore Pillarsetty, Lukas M. Carter, Jason S. Lewis and Thomas Reiner

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1720-1723; DOI: https://doi.org/10.2967/jnumed.120.249748
Open Access
Autoimmune Encephalitis Concomitant with SARS-CoV-2 Infection: Insight from ¹⁸F-FDG PET Imaging and Neuronal Autoantibodies
Stephan Grimaldi, Stanislas Lagarde, Jean-Robert Harlé, José Boucraut and Eric Guedj

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1726-1729; DOI: https://doi.org/10.2967/jnumed.120.249292

Main menu

User menu

Search

SARS-CoV-2